Catheter Precision raises $2.82 million in unregistered sale of Series C-4 preferred stock

• Catheter Precision closed a private placement of 2,821 shares of Series C-4 Convertible Preferred Stock for gross proceeds of USD 2.82 million.
• The securities carry a stated value of USD 1,000 per share; the closing occurred on July 30, 2026.
• Net proceeds earmarked for working capital, general corporate purposes, and redemption of all outstanding Series B Convertible Preferred Stock.
• Dawson James Securities acted as placement agent; the sale relied on Section 4(a)(2) and Rule 506(b) exemptions.
• Series C-4 Preferred ranks senior to common stock; conversion into common stock would dilute existing holders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-025252), on July 31, 2026, and is solely responsible for the information contained therein.